Biorem Inc (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 133 | 109 | 134 | 140 | 185 |
| Income taxes - deferred | 417 | 267 | 15 | -652 | 792 |
| Accounts receivable | 189 | -3,046 | 5,526 | -4,905 | 2,138 |
| Accounts payable and accrued liabilities | 848 | 391 | -1,072 | -934 | 269 |
| Other Working Capital | -808 | -2,513 | 4,451 | -1,413 | -125 |
| Other Operating Activity | 122 | 3,455 | -4,359 | 6,074 | -165 |
| Operating Cash Flow | $901 | $-1,336 | $4,695 | $-1,690 | $3,095 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -249 | -91 | -5 | 0 |
| Investing Cash Flow | $0 | $-249 | $-91 | $-5 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -144 | -187 | -206 | -130 | -202 |
| Other Financing Activity | -100 | 0 | 0 | 157 | 0 |
| Financing Cash Flow | $-244 | $-187 | $-206 | $27 | $-202 |
| Exchange Rate Effect | 37 | -172 | -11 | -394 | 478 |
| Beginning Cash Position | 7,655 | 9,600 | 5,213 | 7,275 | 3,904 |
| End Cash Position | 8,350 | 7,655 | 9,600 | 5,213 | 7,275 |
| Net Cash Flow | $658 | $-1,772 | $4,398 | $-1,668 | $2,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | 901 | -1,336 | 4,695 | -1,690 | 3,095 |
| Capital Expenditure | N/A | -249 | -91 | -5 | N/A |
| Free Cash Flow | 901 | -1,585 | 4,604 | -1,695 | 3,095 |